SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who started this subject11/25/2002 1:07:29 PM
From: nigel bates   of 1022
 
Snippets of possible interest from the recent post on the PPHM thread.
Anyone got chapter & verse on the highlighted claim ? -

Message 18146253
...Peregrine is contracting with three more companies for the creation of a fully human anti-PS mab. Xenerex is still working on it as well...

...THIS IS A BIG DEAL - Peregrine's patents on VTA are process patents. Any targeting antibody conjugated with any effector molecule for the purpose of destroying or blocking tumor neo-vasculature is covered by the company's patents. I asked Ed about other companies developing VTA technology. He told me there were about twenty-five out there and that they've all been contacted and informed that they will eventually need to license through Peregrine...

...No one has ever come to Avid, checked them out, and then gone somewhere else.
Potential revenue from existing capacity - 12 million/yr
+ two 500 liter reactors - 30 million/yr
+ new production suites - 72 million/yr
Work is underway to fit the facilities for two 500 liter reactors. The reactors themselves will not be purchased until contracts require them.
Manufacturing gross profit margin - 50-70%
Avid expects business even in these tough times for two reasons. Big pharmas have the money. Developmental biotechs have no choice. They're burning money and they need mabs for trials...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext